Anna E Strohl1, Joseph M Feinglass2, Shohreh Shahabi3, Melissa A Simon4. 1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Electronic address: anna-strohl@northwestern.edu. 2. Department of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. 3. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. 4. Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Abstract
OBJECTIVE: To evaluate factors associated with delayed surgical treatment among women with endometrial cancer. METHODS: Using the National Cancer Database (NCDB), we analyzed time to first surgery for epithelial endometrial cancer patients who underwent surgical treatment from 2003 to 2011. Poisson regression was used to examine delays >6weeks between diagnosis and surgery, controlled for patients' sociodemographic and clinical characteristics. Survival for women diagnosed between 2003 and 2006 with timely versus delayed surgery was compared using Cox proportional hazards regression. RESULTS: The study included 112,041 women diagnosed at 1108 continuously reporting NCDB hospitals. Survival through 2011 was available for 40,184 women. All patients underwent hysterectomy. Twenty-eight percent of patients underwent surgery >6weeks after diagnosis. Poisson regression estimates indicated that being younger than 40years old, being black or Hispanic, having Medicaid or being uninsured, or being from the lowest education quartile were associated with a significantly higher likelihood of surgical wait time>6weeks. Patients diagnosed in 2010-2011 were more likely (IRR 1.32, 95% CI 1.24-1.40) to undergo surgery >6weeks after diagnosis compared to patients treated in 2003. Survival for women with surgical wait times >6weeks was worse than those treated within 6weeks of diagnosis (HR 1.14, 95% CI 1.09-1.20). CONCLUSIONS: Being a minority patient and having lower socioeconomic status or poor insurance coverage were associated with an increased likelihood of delayed surgical treatment. Wait times >6weeks from diagnosis of endometrial cancer to definitive surgery may have a negative impact on survival.
OBJECTIVE: To evaluate factors associated with delayed surgical treatment among women with endometrial cancer. METHODS: Using the National Cancer Database (NCDB), we analyzed time to first surgery for epithelial endometrial cancerpatients who underwent surgical treatment from 2003 to 2011. Poisson regression was used to examine delays >6weeks between diagnosis and surgery, controlled for patients' sociodemographic and clinical characteristics. Survival for women diagnosed between 2003 and 2006 with timely versus delayed surgery was compared using Cox proportional hazards regression. RESULTS: The study included 112,041 women diagnosed at 1108 continuously reporting NCDB hospitals. Survival through 2011 was available for 40,184 women. All patients underwent hysterectomy. Twenty-eight percent of patients underwent surgery >6weeks after diagnosis. Poisson regression estimates indicated that being younger than 40years old, being black or Hispanic, having Medicaid or being uninsured, or being from the lowest education quartile were associated with a significantly higher likelihood of surgical wait time>6weeks. Patients diagnosed in 2010-2011 were more likely (IRR 1.32, 95% CI 1.24-1.40) to undergo surgery >6weeks after diagnosis compared to patients treated in 2003. Survival for women with surgical wait times >6weeks was worse than those treated within 6weeks of diagnosis (HR 1.14, 95% CI 1.09-1.20). CONCLUSIONS: Being a minority patient and having lower socioeconomic status or poor insurance coverage were associated with an increased likelihood of delayed surgical treatment. Wait times >6weeks from diagnosis of endometrial cancer to definitive surgery may have a negative impact on survival.
Authors: Erik Liederbach; Mark Sisco; Chihsiung Wang; Catherine Pesce; Susan Sharpe; David J Winchester; Katharine Yao Journal: Ann Surg Oncol Date: 2014-09-19 Impact factor: 5.344
Authors: Y H Yun; Y A Kim; Y H Min; S Park; Y J Won; D Y Kim; I J Choi; Y W Kim; S J Park; J H Kim; D H Lee; S J Yoon; S Y Jeong; D Y Noh; D S Heo Journal: Ann Oncol Date: 2012-05-02 Impact factor: 32.976
Authors: Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; David P Winchester; Clifford Y Ko Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: Lisa P Spees; Wendy R Brewster; Mahesh A Varia; Morris Weinberger; Christopher Baggett; Xi Zhou; Victoria M Petermann; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Kyoung Won Noh; Bomi Kim; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Won Kyung Cho; Won Park; Yoo-Young Lee Journal: Cancer Res Treat Date: 2021-04-15 Impact factor: 4.679